Over four decades ago, President Richard Nixon signed the National Cancer Act and the “War on Cancer” was engaged. Now as we look at the progress that has been made and the progress yet to come, executives from PhRMA share the recent results of a study released on over 5000 new drugs in the biopharma pipeline that are taking us forward in the war against cancer and other diseases.
More from PhRMA:
Report: Analysis Group Report
Report: Accompanying PhRMA Report
Related Blog Posts
Examining the Biopharmaceutical Pipeline – Webinar Jan 14, 2013